Myles A. Brown

{{short description|American physician}}

{{Use dmy dates|cs1-dates=ly|date=April 2021}}

{{Use list-defined references|date=April 2021}}

Myles A. Brown is an American oncologist who studies connections between hormones, breast cancer, and prostate cancer,{{r|nas}} particularly focusing on the role of estrogen receptors.{{r|azar}} He is Emil Frei III Professor of Medicine in the Harvard Medical School,{{r|harv}} and director of the Center for Functional Cancer Epigenetics in the Dana–Farber Cancer Institute.{{r|nas}}

Brown was elected to the National Academy of Sciences in 2016,{{r|nas}} the American Academy of Arts and Sciences in 2017,{{r|amacad}} and the National Academy of Medicine in 2020.{{r|nam}}

References

{{reflist|refs=

{{citation|url=https://www.amacad.org/person/myles-brown|title=Dr. Myles A. Brown|work=Member directory|publisher=American Academy of Arts and Sciences|access-date=2021-05-09}}

{{citation

| last = Azar | first = Beth

| date = July 2018

| doi = 10.1073/pnas.1810395115

| issue = 32

| journal = Proceedings of the National Academy of Sciences

| pages = 8054–8056

| title = Profile of Myles Brown

| volume = 115| pmid = 30038006

| pmc = 6094136

| doi-access = free

}}

{{citation|url=https://www.dfhcc.harvard.edu/insider/member-detail/member/myles-brown-md/|title=Myles Brown, MD|publisher=Dana–Farber Cancer Institute|access-date=2021-05-09}}

{{citation|url=https://nam.edu/national-academy-of-medicine-elects-100-new-members-2020/|title=National Academy of Medicine Elects 100 New Members|date=October 19, 2020|publisher=National Academy of Medicine|access-date=2021-05-09}}

{{citation|url=http://www.nasonline.org/member-directory/members/20034172.html|title=Myles A. Brown|work=Member directory|publisher=National Academy of Sciences|access-date=2021-05-09}}

}}